These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35584711)

  • 1. Atrial fibrillation in hypertrophic cardiomyopathy - A contemporary mini-review.
    Dragasis S; Vlachos K; Kariki O; Koskina S; Zygouri A; Patsiotis IG; Anastasakis A; Athanasopoulos G; Ritsatos K; Letsas K; Efremidis M
    Hellenic J Cardiol; 2022; 67():66-72. PubMed ID: 35584711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management.
    Garg L; Gupta M; Sabzwari SRA; Agrawal S; Agarwal M; Nazir T; Gordon J; Bozorgnia B; Martinez MW
    Heart Fail Rev; 2019 Mar; 24(2):189-197. PubMed ID: 30456592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic Cardiomyopathy Predicts Thromboembolism and Heart Failure in Patients With Nonvalvular Atrial Fibrillation　- A Prospective Analysis From the Hokuriku-Plus AF Registry.
    Tsuda T; Hayashi K; Kato T; Kusayama T; Nakagawa Y; Nomura A; Tada H; Usui S; Sakata K; Kawashiri MA; Fujino N; Yamagishi M; Takamura M;
    Circ J; 2023 Nov; 87(12):1790-1797. PubMed ID: 37866911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review.
    Alphonse P; Virk S; Collins J; Campbell T; Thomas SP; Semsarian C; Kumar S
    Clin Res Cardiol; 2021 Apr; 110(4):544-554. PubMed ID: 32880676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.
    Sridharan A; Maron MS; Carrick RT; Madias CA; Huang D; Cooper C; Drummond J; Maron BJ; Rowin EJ
    J Cardiovasc Electrophysiol; 2022 Jan; 33(1):20-29. PubMed ID: 34845799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy.
    Fumagalli C; Zocchi C; Ciabatti M; Milazzo A; Cappelli F; Fumagalli S; Pieroni M; Olivotto I
    Can J Cardiol; 2024 May; 40(5):876-886. PubMed ID: 38286174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enlarged left atrium and sudden death risk in hypertrophic cardiomyopathy patients with or without atrial fibrillation.
    Minami Y; Haruki S; Yashiro B; Suzuki T; Ashihara K; Hagiwara N
    J Cardiol; 2016 Dec; 68(6):478-484. PubMed ID: 26908359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolism in Patients with Hypertrophic Cardiomyopathy.
    Liu L; Liu Z; Chen X; He S
    Int J Med Sci; 2021; 18(3):727-735. PubMed ID: 33437207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.
    Zegkos T; Efthimiadis GK; Parcharidou DG; Gossios TD; Giannakoulas G; Ntelios D; Ziakas A; Paraskevaidis S; Karvounis HI
    Hellenic J Cardiol; 2017; 58(5):331-339. PubMed ID: 28219794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation.
    Fauchier L; Bisson A; Bodin A; Herbert J; Spiesser P; Pierre B; Clementy N; Bernard A; Babuty D; Lip GYH
    Stroke; 2022 Feb; 53(2):497-504. PubMed ID: 34601900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Vaidya K; Semsarian C; Chan KH
    Heart Lung Circ; 2017 Sep; 26(9):975-982. PubMed ID: 28602671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive sleep apnea and hypertrophic cardiomyopathy: a common and potential harmful combination.
    Nerbass FB; Pedrosa RP; Danzi-Soares NJ; Drager LF; Arteaga-Fernández E; Lorenzi-Filho G
    Sleep Med Rev; 2013 Jun; 17(3):201-6. PubMed ID: 23046848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Yashiro B; Minami Y; Terajima Y; Hagiwara N
    J Cardiol; 2014 Jun; 63(6):432-7. PubMed ID: 24280311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy.
    Rouskas P; Zegkos T; Ntelios D; Gossios T; Parcharidou D; Papanastasiou CA; Karamitsos T; Vassilikos V; Kouskouras K; Efthimiadis GK
    Hellenic J Cardiol; 2023; 73():8-15. PubMed ID: 36775018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023.
    Maron BJ; Rowin EJ; Maron MS
    Am J Cardiol; 2024 Feb; 212S():S77-S82. PubMed ID: 38368039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study.
    Jung H; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Thromb Haemost; 2019 Feb; 119(2):285-293. PubMed ID: 30602200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.
    Guttmann OP; Rahman MS; O'Mahony C; Anastasakis A; Elliott PM
    Heart; 2014 Mar; 100(6):465-72. PubMed ID: 24014282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of Late Gadolinium Enhancement Predicts Thromboembolic Events in Patients With Hypertrophic Cardiomyopathy.
    Hohneck A; Overhoff D; Doesch C; Sandberg R; Rudic B; Tueluemen E; Budjan J; Szabo K; Borggrefe M; Papavassiliu T
    Circ J; 2020 Apr; 84(5):754-762. PubMed ID: 32238665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.